...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AACR 2018
2
Jan 18, 2018 04:07PM
5
Feb 21, 2018 11:38AM
3
Feb 21, 2018 05:45PM
4
Feb 21, 2018 05:52PM
5
Feb 22, 2018 10:34AM
4
Feb 22, 2018 02:25PM
3
Feb 23, 2018 02:54AM
3
Feb 23, 2018 11:14AM
3
Feb 23, 2018 12:41PM
3
Feb 27, 2018 06:33PM
1
Feb 27, 2018 08:43PM
4
Feb 28, 2018 10:42AM
2
Feb 28, 2018 05:41PM
3
Feb 28, 2018 05:57PM
2
Mar 01, 2018 05:17PM
2
Mar 01, 2018 09:35PM

I wonder, with ABBVie and others in this area it is a busy field. That could be very good for profile with investors. The companies in this field have big money to spend.

I feel the challenge is what does Don have to attract a $10 million investor to Zenith. There is no recent info on the zen3694 trial and the results to date are very mixed.

I would assume that raising money for RVX is by far Don's top priority and that seems to be dragging, to say the least.

Perhaps a good story will immerge on the science side to give Don something to sell?

My personal feeling is that the situation is not well organized at Zenith Epi. Hopefully the scientists are still beavering away but at some point they will need $.

Toinv

2
Mar 05, 2018 03:59PM
2
Mar 05, 2018 11:08PM
3
Mar 06, 2018 03:46AM
2
Mar 06, 2018 10:13AM
2
Mar 06, 2018 01:15PM
2
Mar 06, 2018 01:24PM
2
Mar 21, 2018 11:36AM
3
Apr 13, 2018 09:23AM
Share
New Message
Please login to post a reply